Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

Eli Lilly and Company (LLY)’s share was trading at $794.10 as of May 1st. LLY’s trailing and forward P/E were 64.61 and 35.34 respectively according to Yahoo Finance.

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

LOUISVILLE, Ky. (WAVE) - Eli Lilly and Company, a pharmaceutical company headquartered in Indianapolis, plans to investment more at the LEAP Research and Innovation District in Lebanon. That’s ...

Eli Lilly and Company (NYSE:LLY) Morgan Stanley 22nd Annual Global Healthcare Conference Call September 5, 2024 7:45 AM ET. Company Participants.

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.